Capital Advantage, Inc.: CGMS position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Capital Advantage, Inc. on CGMS, newest first. How the timeline and the estimate are built.
Capital Advantage, Inc. held 3,791,682 CGMS shares at 2026-06-30 per its 13F-HR filed 2026-07-13.
the latest 13F is the newest step
- period ended2026-06-3013F 3,791,682 sharesChange vs previous 13F +1,292,902 shares
12.64% of the 13F portfolio, value $103,626,677.
13F-HR 0002085853-26-000699 filed by Capital Advantage, Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 2,498,780 sharesChange vs previous 13F +190,612 shares
8.89% of the 13F portfolio, value $68,041,791.
13F-HR 0002085853-26-000344 filed by Capital Advantage, Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 2,308,168 sharesChange vs previous 13F +138,954 shares
8.6% of the 13F portfolio, value $63,751,608.
13F-HR 0002085853-26-000016 filed by Capital Advantage, Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 2,169,214 sharesChange vs previous 13F +60,898 shares
9.05% of the 13F portfolio, value $60,195,690.
13F-HR 0002085853-25-000139 filed by Capital Advantage, Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 2,108,316 sharesChange vs previous 13F not available
9.22% of the 13F portfolio, value $58,231,678.
13F-HR 0001667731-25-000784 filed by Capital Advantage, Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).